HSS Journal

, Volume 6, Issue 2, pp 155–159 | Cite as

A Randomized Controlled Trial of Intraarticular Ropivacaine for Pain Management Immediately Following Total Knee Arthroplasty

  • Adam S. Rosen
  • Clifford W. ColwellJr
  • Pamela A. Pulido
  • Tricia L. Chaffee
  • Steven N. Copp
Original Article

Abstract

Total knee arthroplasty (TKA) is a commonly performed procedure for the treatment of end-stage arthritis of the knee. Pain control following TKA is difficult to manage in some patients. We examined the use of a postoperative intraarticular injection of 100 mL of 0.2% (200 mg) ropivacaine in a double-blind, prospective, placebo-controlled pilot study to evaluate its use as a pain control modality. All patients received general anesthesia. Postoperatively, patients were placed on intravenous patient-controlled analgesia with morphine. The ropivacaine group showed an early trend in lower visual analog scale (VAS) scores when compared with the placebo group. Patients receiving ropivacaine used a similar amount of narcotics compared with the placebo group. Intraarticular ropivacaine used for pain control after TKA demonstrated no statistically significant difference in lowering VAS scores or narcotic usage; therefore, intraarticular ropivacaine as a single modality is not recommended for effective pain management.

Keywords

total knee arthroplasty ropivacaine intraarticular injection pain control randomized controlled trial 

References

  1. 1.
    U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2006 National Hospital Discharge Survey. Available at: http://www.cdc.gov/nchs/nhds.htm. Accessed Oct 7, 2009.
  2. 2.
    Badner NH, Bourne RB, Rorabeck CH, et al. Intra-articular injection of bupivacaine in knee-replacement operations. Results of use for analgesia and for preemptive blockade. J Bone Joint Surg Am. 1996; 78: 734–738.PubMedGoogle Scholar
  3. 3.
    Browne C, Copp S, Reden L, et al. Bupivacaine bolus injection versus placebo for pain management following total knee arthroplasty. J Arthroplasty. 2004; 19: 377–380.CrossRefPubMedGoogle Scholar
  4. 4.
    Busch CA, Shore BJ, Bhandari R, et al. Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am. 2006; 88: 959–963.CrossRefPubMedGoogle Scholar
  5. 5.
    Hebl JR, Kopp SL, Ali MH, et al. A comprehensive anesthesia protocol that emphasizes peripheral nerve blockade for total knee and total hip arthroplasty. J Bone Joint Surg Am. 2005; 87 Suppl 2: 63–70.CrossRefPubMedGoogle Scholar
  6. 6.
    Ritter MA, Koehler M, Keating EM, et al. Intra-articular morphine and/or bupivacaine after total knee replacement. J Bone Joint Surg Br. 1999; 81: 301–303.CrossRefPubMedGoogle Scholar
  7. 7.
    Walker RH, Morris BA, Angulo DL, et al. Postoperative use of continuous passive motion, transcutaneous electrical nerve stimulation, and continuous cooling pad following total knee arthroplasty. J Arthroplasty. 1991; 6: 151–156.PubMedGoogle Scholar
  8. 8.
    Pham Dang C, Gautheron E, Guilley J, et al. The value of adding sciatic block to continuous femoral block for analgesia after total knee replacement. Reg Anesth Pain Med. 2005; 30: 128–133.CrossRefPubMedGoogle Scholar
  9. 9.
    Chelly JE, Greger J, Gebhard R, et al. Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty. J Arthroplasty. 2001; 16: 436–445.CrossRefPubMedGoogle Scholar
  10. 10.
    Ben-David B, Schmalenberger K, Chelly JE Analgesia after total knee arthroplasty: Is continuous sciatic blockade needed in addition to continuous femoral blockade? Anesth Analg. 2004; 98: 747–749, table of contents.CrossRefPubMedGoogle Scholar
  11. 11.
    Lombardi AV, Jr., Berend KR, Mallory TH, et al. Soft tissue and intra-articular injection of bupivacaine, epinephrine, and morphine has a beneficial effect after total knee arthroplasty. Clin Orthop Relat Res. 2004; 125–130.Google Scholar
  12. 12.
    Convery PN, Milligan KR, Quinn P, et al. Efficacy and uptake of ropivacaine and bupivacaine after single intra-articular injection in the knee joint. Br J Anaesth. 2001; 87: 570–576.CrossRefPubMedGoogle Scholar
  13. 13.
    Marret E, Gentili M, Bonnet MP, et al. Intra-articular ropivacaine 0.75% and bupivacaine 0.50% for analgesia after arthroscopic knee surgery: A randomized prospective study. Arthroscopy. 2005; 21: 313–316.CrossRefPubMedGoogle Scholar
  14. 14.
    Knudsen K, Beckman Suurkula M, Blomberg S, et al. Central nervous and cardiovascular effects of I.V. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997; 78: 507–514.PubMedGoogle Scholar
  15. 15.
    Wienzek H, Freise H, Giesler I, et al. Altered blood flow in terminal vessels after local application of ropivacaine and prilocaine. Reg Anesth Pain Med. 2007; 32: 233–239.PubMedGoogle Scholar
  16. 16.
    Drug facts and comparisons. 60th edn. St Louis, MO: Lippincott Williams & Wilkins 2006.Google Scholar
  17. 17.
    Bianconi M, Ferraro L, Traina GC, et al. Pharmacokinetics and efficacy of ropivacaine continuous wound instillation after joint replacement surgery. Br J Anaesth. 2003; 91: 830–835.CrossRefPubMedGoogle Scholar

Copyright information

© Hospital for Special Surgery 2010

Authors and Affiliations

  • Adam S. Rosen
    • 1
  • Clifford W. ColwellJr
    • 1
  • Pamela A. Pulido
    • 2
  • Tricia L. Chaffee
    • 1
  • Steven N. Copp
    • 1
  1. 1.Division of Orthopaedic SurgeryScripps ClinicLa JollaUSA
  2. 2.Shiley Center for Orthopaedic Research and Education at Scripps ClinicScripps HealthLa JollaUSA

Personalised recommendations